Press release
Acquired Orphan Blood Diseases Therapeutics Market to Boom; Increasing Prevalence of Blood Disorders to Bolster Industry Growth: Fortune Business Insights™
Acquired Orphan Blood Diseases Therapeutics
The global acquired orphan blood diseases therapeutics market size is expected to grow exponentially because of the rising cases of blood disorders among the population. The increasing awareness regarding blood disorders is expected to boost market growth. Fortune Business Insights™ mentions this information in its report, titled, "Acquired Orphan Blood Diseases Therapeutics Market, 2021-2028."
Acquired orphan blood diseases therapeutics are a therapy used to cure rare blood diseases, wherein the lack of red blood cells negatively affects the health of the person suffering from the disease. It is used to cure diseases, such as myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria (PNH), and acquired agranulocytosis. Further, the rising awareness among the population regarding blood disorders is expected to increase the demand for advanced therapies. The rising investment in healthcare sectors can enhance the demand for acquired orphan blood diseases therapeutics. Thus, these factors can enhance the market growth during the foreseeable period.
Request a Sample Copy of the Research Report
Impact of COVID-19
Rising Demand from Healthcare Sector to Boost Market Growth
This market is expected to be positively impacted during the COVID-19 pandemic due to the rising demand for advanced blood therapies, such as acquired orphan blood diseases therapeutics from the healthcare sector. The rising cases of blood disorders can lead to the adoption of advanced treatment procedures. The demand for advanced medical equipment and procedures such as acquired orphan blood diseases therapeutics is increasing during the pandemic, which, in turn, enhances production activities. Manufacturers are operating at reduced capacities and implementing safety procedures to avoid the spread of the virus. Therefore, these factors can enhance the market growth during the pandemic.
To get to know more about the short-term and long-term impact of COVID-19 on this market, please visit: https://www.fortunebusinessinsights.com/acquired-orphan-blood-diseases-therapeutics-market-102010
Segments
By therapy, the market is segregated into thrombopoietin receptor agonists, activated prothrombin complex concentrate, immunoglobulin infusion therapy, recombinant factor, and others. As per disease, it is divided into myelodysplastic syndrome, paroxysmal nocturnal hemoglobinuria (PNH), acquired von willebrand syndrome, acquired hemophilia, acquired agranulocytosis, and others. Based on distribution channels, it is categorized intoretail pharmacy, hospital pharmacy, and others. Geographically, it is clubbed into Europe, North America, Latin America, Asia Pacific, and the Middle East & Africa.
Highlights of the Report
The report highlights the latest market trends and the leading segments.
It conducts a comprehensive analysis of the impact of COVID-19 and the driving and restraining factors.
This report examines the regional development and the strategies deployed by the prominent companies operating in the market.
Quick Buy Acquired Orphan Blood Diseases Therapeutics
Drivers and Restraints
Increasing Awareness Regarding Blood Disorders to Propel Market Growth
The increasing awareness regarding the causes of blood disorders among the population can enhance the demand for acquired orphan blood diseases therapeutics. The prevalence of the disorder is increasing rapidly among the geriatric population, thereby driving the sales of the product. Further, governments are undertaking several initiatives to increase awareness among the population regarding several blood disorders. The stringent lifestyles of people can increase the prevalence of such blood disorders, which, in turn, necessitates the adoption of advanced orphan blood diseases therapeutics procedures, drugs, and other solutions. Therefore, these factors can drive the acquired orphan blood diseases therapeutics market growth.
However, strict government regulations on blood treatment procedures can hamper market growth.
Have Any Query? Ask Our Experts
Regional Insights
Heavy Investment on Research and Development Activities to Foster Market Growth in North America
North America is expected to lead in terms of the acquired orphan blood disease therapeutics market share due to heavy investments in research and development of better treatment procedures in the U.S. As per Statistica, approximately 13,000 patients suffer from von willebrand syndrome and about 18,000 patients have hemophilia. In addition, the prevalence of several blood disorders can boost the market growth.
In Europe, the rising cases of blood disorders among the population are expected to boost the demand for acquired orphan blood diseases therapeutics. Hence, this factor can propel market growth.
In Asia Pacific and Latin America, acquired orphan blood diseases therapeutics' increasing awareness can stoke market growth.
Competitive Landscape
Prominent Companies Announce FDA Approved Treatment Procedures to Enhance Brand Image
Prominent players operating in the market are announcingthe launch of advanced FDA-approved treatment procedures to improve their brand image. For example, the U.S. FDA approved ADDMEDICA's Orphan Drug Siklos in March 2018. Simultaneously, its sole hydroxyurea-based sickle cell anemia treatment was also approved by the U.S. FDA. This approval enabled the company to enhance its brand image globally. Additionally, significant investments in research and development procedures would lead to the emergence of better acquired orphan blood diseases therapeutics procedure. This strategy can helpcompanies to develop better treatment procedures and improve their market positions.
Industry Development
February 2019: Cablivi (caplacizumab-yhdp) injection received the U.S. FDA approval alongside immunosuppressive therapy and plasma exchange to cure thrombotic thrombocytopenic purpura (aTTP).
List of Key Players Profiled in the Acquired Orphan Blood Diseases Therapeutics Market Report
Amgen Inc.
Shire plc
Alexion Pharmaceuticals
Celgene Corporation
Rigel Pharmaceuticals, Inc.
Otsuka Pharmaceutical Pvt. Ltd.
Novo Nordisk Inc.
About Us:
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
Contact Us:
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
LinkedIn: https://www.linkedin.com/company/fortune-business-insights
Facebook: https://www.facebook.com/FortuneBusinessInsightsPvtLtd
Twitter: https://twitter.com/FBInsightPvtLtd
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acquired Orphan Blood Diseases Therapeutics Market to Boom; Increasing Prevalence of Blood Disorders to Bolster Industry Growth: Fortune Business Insights™ here
News-ID: 2372790 • Views: …
More Releases from Fortune Business Insights
Future of Renewable Energy Market Insights: Growth Drivers, and Regional Develop …
Global Renewable Energy Market Overview
The global renewable energy market size was valued at USD 954 billion in 2023. The market is projected to grow from USD 1,020.94 billion in 2024 to USD 1,574.17 billion by 2032, exhibiting a CAGR of 5.56% during the forecast period. Asia Pacific dominated the renewable energy market with a market share of 67.76% in 2023. The Renewable energy market in the U.S. is projected to…
DC Drives Market Overview: Opportunities, Growth Drivers, and Key Applications
Market Overview
The global DC drives market size was valued at USD 4.34 billion in 2018 and is projected to reach USD 9.23 billion by 2032, exhibiting a CAGR of 5.59% during the forecast period of 2019-2032. Asia Pacific dominated the global market with a share of 28.8% in 2018. The DC drives market in the U.S. is projected to grow significantly, reaching an estimated value of USD 1.59 billion by…
Humanoid Robots Market: An In-depth B2B Analysis of Size, Share, and Future Grow …
Brief Market Overview:
The global humanoid robots market is rapidly transitioning from a nascent field into a major growth sector, with its value escalating from USD 2.43 billion in 2023 to a projected USD 66.0 billion by 2032, demonstrating a remarkable CAGR of 45.5%.
These complex machines, which merge mechanical, electrical, and software engineering, are moving beyond research labs into real-world applications across industrial, service, and household sectors. This explosive growth…
Methanol Market Poised for Remarkable Growth, set to Reach USD 46.32 billion by …
The global methanol market size was valued at USD 31.26 billion in 2023. It is projected to grow from USD 32.70 billion in 2024 to USD 46.32 billion by 2032, exhibiting a CAGR of 4.5% during the forecast period.
The global methanol market size is set to gain traction from the urgent need to lower environmental pollution caused by the surging usage of heavy fuels, such as diesel and gasoline. Pollution…
More Releases for Acquired
Rising Incidence Of Hospital-Acquired Infections Fuels Growth In Hospital Acquir …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Hospital Acquired Infections Testing Kits Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
The market size for kits testing hospital-acquired infections has seen substantial growth in the recent past. The market, currently valued at $4.54 billion in 2024, is projected to expand to $4.83 billion…
Acquired Orphan Blood Disease Market
Acquired Orphan Blood Disease Market to reach over USD 18.93 billion by the year 2031 - Exclusive Report by InsightAce Analytic
According to a new report by InsightAce Analytic, the "Acquired Orphan Blood Disease Market" in terms of revenue was estimated to be worth $8.65 billion in 2023 and is poised to reach $18.93 billion by 2031, growing at a CAGR of 10.47% from 2024 to 2031.
Get Free Access to…
Community-Acquired Bacterial Pneumonia Market
DelveInsight's "Community-Acquired Bacterial Pneumonia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of the Community-Acquired Bacterial Pneumonia, historical and forecasted epidemiology as well as the Community-Acquired Bacterial Pneumonia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Community-Acquired Bacterial Pneumonia market report provides current treatment practices, emerging drugs, Community-Acquired Bacterial Pneumonia market share of the individual therapies, and current…
Hospital Acquired Disease Testing Market - Enhancing Patient Safety: Comprehensi …
Newark, New Castle, USA: The "Hospital Acquired Disease Testing Market" provides a value chain analysis of revenue for the anticipated period from 2022 to 2030. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors
Hospital Acquired Disease Testing Market: https://www.growthplusreports.com/report/hospital-acquired-disease-testing-market/7807
This latest report researches the…
SOS acquired by PracticeEvolve
Solicitors Own Software (SOS) have announced the sale of the business to PracticeEvolve Group to continue to provide the market with progressive technology, supported by strong service and support.
Operating since 1987, SOS have delivered practice and case management software and services to law firms across the UK. With over 17,000 users and a solid client base, Graham Colbourne, Managing Director, says the sale will ensure the market is provided…
Pneumonia Drug Development Market Focuses on Top Players (Hospital Acquired Pneu …
Pneumonia Drug Development Market study provides comprehensive data which enhances the understanding, scope and application of this report. Polyamides, polyethylene, nylons, epoxy resins, polysulfones, polyphthalamides, polyesters, and polycarbonates are some key forms of plastics that are employed in electronic components. The insulation properties of plastic account for its in depth use in electrical and electronic components of machines and gadgets.
Report Consultant has introduced a new report titled as Global Pneumonia…
